Skip to main content
SpringerLink
Log in

Estrogen and Vascular Reactivity

  • Chapter
Endocrinology of the Vasculature

Part of the book series: Contemporary Endocrinology ((COE,volume 1))

Abstract

Cardiovascular disease is the leading cause of death in American women, claiming more lives than cancer, diabetes, and accidents combined (1,2). The risk of myocardial infarction and stroke increases dramatically in women after the menopause (3). Of women ages 45-64 yr, one of nine have cardiovascular disease; yet after age 65, the ratio increases to one of three (2). Loss of endogenous estrogens associated with menopause contributes to the increased cardiovascular risk. Conversely, in postmenopausal women taking estrogen replacement therapy, population-based studies indicate there are up to 50% fewer cardiovascular events (4,5). These observations support an important role for estrogen replacement therapy in the prevention of cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Eaker ED, Chesebro JK, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation 1993;88:1999–2009.

    Article  PubMed  CAS  Google Scholar 

  2. Sempos CT, Cleeman JI, Carroll MD, Johnson CI, Bachorik PS, Gordon DJ, Burt VI, Briefel RR, Brown CD, Lippel K, Rifkind BM. Prevalence of high blood pressure among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009–3014.

    Article  PubMed  CAS  Google Scholar 

  3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265: 1861–1867.

    Article  PubMed  CAS  Google Scholar 

  4. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses Health Study. N Engl J Med 1991;325:756–762.

    Article  PubMed  CAS  Google Scholar 

  5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster YL, Cumings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Int Med 1992;117:1016–1037.

    PubMed  CAS  Google Scholar 

  6. Rosenberg L, Armstrong B, Jick H. Myocardial infarction and estrogen therapy in postmenopausal women. N Engl J Med 1976;294:1256–1259.

    Article  PubMed  CAS  Google Scholar 

  7. Pfeffer RI, Whipple GH, Kurosaki TT, Chapman JM. Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol 1978;107:479–497.

    PubMed  CAS  Google Scholar 

  8. Rosenberg L, Slone D, Shapiro S, Kaufman D, Stolley PD, Miettinen DS. Noncontraceptive estrogen use and myocardial infarction in young women. JAMA 1980;244:339–342.

    Article  PubMed  CAS  Google Scholar 

  9. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981;1:858–860.

    Article  PubMed  CAS  Google Scholar 

  10. Bain C, Willet W, Henderson CH, Rosner B, Belanger C, Speizer PE. Use of postmenopausal hormones and risk of myocardial infarction. Circulation 1981;64:42–46.

    Article  PubMed  CAS  Google Scholar 

  11. Adam D, Williams V, Vessey MP. Cardiovascular disease and hormone replacement treatment. Br Med J 1981;282:1277–1278.

    Article  CAS  Google Scholar 

  12. Szklo M, Tonascia J. Gordes L, Bloom I. Estrogen use and myocardial infarction: a case-control study. Prey Med 1984;13:510–516.

    Article  CAS  Google Scholar 

  13. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Community Health 1989;43:173–178.

    Article  PubMed  CAS  Google Scholar 

  14. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062–1071.

    Article  PubMed  CAS  Google Scholar 

  15. Burch JC, Byrd BR Jr, Vaughn WK. The effects of long term estrogen use in hysterectomized women. Am J Obstet Gynecol 1974;188:778–782.

    Google Scholar 

  16. Petitti DB, Wingerd J, Pellegrin F, Ramcharan S. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens and other factors. JAMA 1979;242:1150–1154.

    Article  PubMed  CAS  Google Scholar 

  17. Hammond CB, Jelovsek FR, Lee KL, Creesman WT, Parker RT. Effects of long term ERT. Am J Obstet Gynecol 1979;133:525–536.

    PubMed  CAS  Google Scholar 

  18. Wilson PWF, Garrison RJ, Casselli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham Study. N Engl J Med 1985;313:1038–1043.

    Article  PubMed  CAS  Google Scholar 

  19. Stampfer MJ, Wille WC, Colditz GA, Rosner B, Speitzer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044–1049.

    Article  PubMed  CAS  Google Scholar 

  20. Petitti DB, Perlman JA, Sidney S. Postmenopausal estrogen use and heart disease. N Engl J Med 1986;315:131–132.

    Article  Google Scholar 

  21. Petitti DB, Perlman JA, Sidney S. Noncontraceptive estrogens and mortality: long term follow up from the Walnut Creek Study. Obstet Gynecol 1987;70:289–293.

    PubMed  CAS  Google Scholar 

  22. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol 1987;94:620–635.

    Article  CAS  Google Scholar 

  23. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program follow-up study. Circulation 1987;75:1102–1109.

    Article  PubMed  CAS  Google Scholar 

  24. Henderson BE, Paganini-Hill A, Ross RK. ERT and protection from acute myocardial infarction. Am J Obstet Gynecol 1988;159:312–317.

    PubMed  CAS  Google Scholar 

  25. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J. Wingerd DL, Garland C. Postmenopausal estrogen use and mortality: a prospective study in a defined homogenous community. Am J Epidemiol 1988;128:606–614.

    PubMed  CAS  Google Scholar 

  26. Boysen G, Nyboe J, Appleyard M, Sorenson PS, Boas J, Somnier F. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 1988;18:1345–1353.

    Article  Google Scholar 

  27. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal estrogen use and stroke: a prospective study. Br Med J 1988;297:519–522.

    Article  CAS  Google Scholar 

  28. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Int Med 1991;151:75–78.

    Article  CAS  Google Scholar 

  29. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Arch Int Med 1993;153:73–79.

    Article  CAS  Google Scholar 

  30. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987;19:90–95.

    PubMed  CAS  Google Scholar 

  31. Weigensberg BI, Lough J, More RH, Katz E, Pugash E, Peniston C. Effects of estradiol on myointimal thickening from catheter injury and on organizing white mural non-occlusive thrombi. Atherosclerosis 1984;52:253–265.

    Article  PubMed  CAS  Google Scholar 

  32. Adams MR, Kaplan JR, Clarkson TB, Koritnik DR. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 1985;5:192–200.

    Article  PubMed  CAS  Google Scholar 

  33. Williams JK, Adams MR, Klopfenstein HB. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680–1687.

    Article  PubMed  CAS  Google Scholar 

  34. Kushwaha RS, Hazzard WR. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 1981;30:359–366.

    Article  PubMed  CAS  Google Scholar 

  35. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by estrogen in ovariectomized monkeys Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051–1057.

    Article  PubMed  CAS  Google Scholar 

  36. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991;88:1995–9002.

    Article  PubMed  CAS  Google Scholar 

  37. Maziere C, Auclair M, Ronveux MF, Salmon S, Santus R, Maziere JG. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 1990;89:175–182.

    Article  Google Scholar 

  38. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effect of estrogen against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:207–217.

    Article  PubMed  CAS  Google Scholar 

  39. Keaney JF, Shwaery GT, Xu A, Nicolosi RI, Loscalzo J, Foxall TL, Vita JA. 17 0-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 1994;89:2251–2259.

    Article  PubMed  CAS  Google Scholar 

  40. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 1995;15:827–836.

    Article  PubMed  CAS  Google Scholar 

  41. Matthews KA, Meilahn E, Kuller LH, Kelsey ST, Caggiula AW, Wing RR. Menopause and risk factors for CAD. N Engl J Med 1989;321:641–646.

    Article  PubMed  CAS  Google Scholar 

  42. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83–90.

    Article  PubMed  CAS  Google Scholar 

  43. Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P. The lowering of lipoprotein [a] induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993;153:1462–1468.

    Article  PubMed  CAS  Google Scholar 

  44. Mendoza S, Velasquez E, Osona A, Hamer T, Glueck CJ. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein [a]. J Lab Clin Med 1994;123:837–841.

    PubMed  CAS  Google Scholar 

  45. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects ofpostmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325: 1196–1204.

    Article  PubMed  CAS  Google Scholar 

  46. Lafferty FW, Fiske ME. Postmenopausal estrogen replacement: a long-term cohort study. Am J Med 1994;97:66–76.

    Article  PubMed  CAS  Google Scholar 

  47. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of ERT on serum lipid values and angiographically defined CAD in postmenopausal women. Am J Cardiol 1992;69:176–178.

    Article  PubMed  CAS  Google Scholar 

  48. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994;154:1106–1110.

    Article  PubMed  CAS  Google Scholar 

  49. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1993;328:1069–1075.

    Article  PubMed  CAS  Google Scholar 

  50. Walsh BW, Li H, Sacks FM. Effects ofpostmenopausal hormone replacement with oral and transdermal estrogen on HDL metabolism. J Lipid Res 1994;35:2083–2093.

    PubMed  CAS  Google Scholar 

  51. Tikkanen MN, Nikkilä EA, Kuusic T, Sipiner S. Different effects of two progestins on plasma high density lipoprotein (HDL2) and post-heparin plasma hepatic lipase activity. Atherosclerosis 1981;40:365–369.

    Article  PubMed  CAS  Google Scholar 

  52. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1994;273:199–208.

    Google Scholar 

  53. Hill JS, Hayden MR, Frolich J, Pritchard PH. Genetic and environmental factors affecting the incidence of CAD in heterozygous familial hypercholesterolemia. Arterioscler Thromb 1991;11:290–297.

    Article  PubMed  CAS  Google Scholar 

  54. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ, Selwyn AP, Ganz P. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of CAD. Circulation 1993;87:V56–V66.

    Google Scholar 

  55. Zeiher AM, Schray-Utz B, Busse R. NO modulates chemoattractant protein 1 in human endothelial cells: implications for the pathogenesis of atherosclerosis. Circulation 1993;88: 1–367 (abstract).

    Google Scholar 

  56. Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. NO and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 1991;11:254–260.

    Article  PubMed  CAS  Google Scholar 

  57. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol 1988;94:1020–1022.

    Article  PubMed  CAS  Google Scholar 

  58. Garg UC, Hassid A. NO generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83: 1774–1777.

    Article  PubMed  CAS  Google Scholar 

  59. Hayashi T, Fukoto JM, Ignarro LJ, Chaudhuri C. Basal release of NO from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci 1992;89: 11,259–11,263.

    Article  Google Scholar 

  60. Gisclard V, Miller VM, Vanhoutte PM. Effect of estrogen on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988;244:19–22.

    PubMed  CAS  Google Scholar 

  61. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991;261:1022–1027.

    Google Scholar 

  62. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol 1995;268: H377–H383.

    PubMed  CAS  Google Scholar 

  63. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452–457.

    Article  PubMed  CAS  Google Scholar 

  64. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994;24: 1757–1761.

    Article  PubMed  CAS  Google Scholar 

  65. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to ACh in postmenopausal women. Circulation 1994;89:52–60.

    Article  PubMed  CAS  Google Scholar 

  66. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545–2551.

    Article  PubMed  CAS  Google Scholar 

  67. Lieberman EH, Gerhard M, Yeung AC, Anderson TJ, Meredith IT, Ganz P, Selwyn AP. Estrogen improves coronary vasomotor responses to ACh in postmenopausal women. Circulation 1993;88:1–79 (abstract).

    Google Scholar 

  68. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA. Estrogen attenuates ACh-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24–30.

    Article  PubMed  CAS  Google Scholar 

  69. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with CAD. Lancet 1993;342:133–136.

    Article  PubMed  CAS  Google Scholar 

  70. Gerhard MD, Roddy MA, Knab ST, Creager SJ, Creager MA. Acute estrogen administration improves endothelium-dependent vasodilation in postmenopausal women. Circulation 1994;88:1–369 (abstract).

    Google Scholar 

  71. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786–791.

    Article  PubMed  CAS  Google Scholar 

  72. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann Int Med 1994;121:936–941.

    PubMed  CAS  Google Scholar 

  73. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454–456.

    Article  PubMed  CAS  Google Scholar 

  74. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985:364:45–56.

    PubMed  CAS  Google Scholar 

  75. Harrison DG, OHara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol 1995;75:75B–81B.

    Article  PubMed  CAS  Google Scholar 

  76. Sugioka JM, Shimosegawa Y, Nakano MM. Estrogens as natural antioxidants of membrane lipid peroxidation. FEBS Lett 1987;210:37–39.

    Article  PubMed  CAS  Google Scholar 

  77. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269–270.

    Article  PubMed  CAS  Google Scholar 

  78. Rosser M, Chorich L, Howard E, Zamorano P, Mahesh VB. Changes in rat uterine receptor messenger ribonucleic acid levels during estrogen and progesterone induced estrogen receptor depletion and subsequent replenishment. Biol Reprod 1993;48:89–98.

    Article  PubMed  CAS  Google Scholar 

  79. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent NOSs by sex hormones. Proc Natl Acad Sci USA 1994;91:5212–5216.

    Article  PubMed  CAS  Google Scholar 

  80. Miller VM, Gisclard V, Vanhoutte PM. Modulation of endothelium-dependent and vascular smooth muscle responses by estrogens. Phlebology 1988;3:63–69.

    Google Scholar 

  81. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation ofprostacyclin activity in rat aorta smooth muscle cells in culture. Biochim Biophys Acta 1980;619:107–118.

    Article  PubMed  CAS  Google Scholar 

  82. Gisclard V, Flavahan NA, Vanhoutte PM. Alpha adrenergic responses, of blood vessels of rabbits after ovariectomy and administration of estrogen. J Pharmacol Exp Ther 1987;240:466–470.

    PubMed  CAS  Google Scholar 

  83. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 1713-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271–H275.

    PubMed  CAS  Google Scholar 

  84. Zhang F. Ram JL, Standley PR, Sowers JR. 1713-estradiol attenuates voltage-dependent Caz+ currents in vascular smooth muscle. Am J Physiol 1994;193:C975–C980.

    Google Scholar 

  85. Jiang C, Sarrel PM, Lindsey DC, Poole-Wilson PA, Collins P. Estrogen has calcium antagonistic properties in the rabbit coronary artery in vitro. Circulation 1991;84:II-272 (abstract).

    Google Scholar 

  86. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol 1979;100:375–382.

    Article  PubMed  CAS  Google Scholar 

  87. Beldekas JC, Smith B, Gerstenfeld LC, Sonenshein GE, Franzblau C. Effects of estrogen on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 1981;20:2162–2167.

    Article  PubMed  CAS  Google Scholar 

  88. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 1985;54:1770–1785.

    Article  Google Scholar 

  89. Fischer GM, Cherian K, Swain ML. Increased synthesis of aortic collagen and elastin in experimental atherosclerosis. Atherosclerosis 1981;39:463–467.

    Article  PubMed  CAS  Google Scholar 

  90. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW. Estrogen promotes angiogenesis activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995;91:755–763.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Marie D. Gerhard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Creager MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, Wayne State University, Detroit, Michigan, USA

    James R. Sowers MD

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gerhard, M.D., Creager, M.A. (1996). Estrogen and Vascular Reactivity. In: Sowers, J.R. (eds) Endocrinology of the Vasculature. Contemporary Endocrinology, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0231-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0231-8_5

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6672-3

  • Online ISBN: 978-1-4612-0231-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation